FDA Blocked Melanoma Drug Amidst Clinical Trial Confusion
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.